Drug intelligence / Profile preview

naproxen + cholecalciferol

Development stage
Unknown
Lead developer
Humax
Modality
Small Molecules
Administration
Oral
01

Overview

OKSON D3 is a fixed-dose combination pharmaceutical product developed and marketed by Humax Pharmaceutical, a Colombian subsidiary of Bausch Health. It contains the nonsteroidal anti-inflammatory drug (NSAID) **naproxen** and **cholecalciferol** (Vitamin D3). The product is indicated for the symptomatic treatment of chronic inflammatory conditions, including rheumatoid arthritis, osteoarthritis, and ankylosing spondylitis, particularly in patients who are at risk of Vitamin D deficiency. Naproxen provides relief from pain and inflammation by inhibiting the cyclooxygenase enzymes (COX-1 and COX-2), while cholecalciferol helps maintain bone health and calcium balance, which is often compromised in patients with chronic joint diseases or those on long-term medication.

Brand names
OKSON D3
Other names
Naproxen/Vitamin D3Naproxen/Cholecalciferol
02

Targets

PGHS-1 (Prostaglandin G/H Synthase 1)VDR (Vitamin D receptor)

Beyond the preview

Go deeper on naproxen + cholecalciferol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on naproxen + cholecalciferol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call